Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7.11% is 81% above its 5-year average of -37.99%, near the high end of its 5-year range (-95.67%–7.10%).
24.78% above its 12-month average of -9.45%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -8.90%.
NET PROFIT MARGIN
-7.11%
NET PROFIT MARGIN AVG TTM
-9.45%
NET PROFIT MARGIN AVG 3Y
-13.87%
NET PROFIT MARGIN AVG 5Y
-37.99%
NET PROFIT MARGIN AVG 10Y
-45.61%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+24.78%
CURRENT VS 3Y AVG
+48.74%
CURRENT VS 5Y AVG
+81.28%
CURRENT VS 10Y AVG
+84.41%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-181.91%
vs the sector median at left
Natera, Inc.
Market Cap
$58.77B
Net Profit Margin
-7.11%
TTM Avg
-9.45%
3Y Avg
-13.87%
5Y Avg
-37.99%
Market Cap
$63.32B
Net Profit Margin
17.47%
TTM Avg
12.73%
3Y Avg
10.54%
5Y Avg
8.34%
Market Cap
$53.47B
Net Profit Margin
0.67%
TTM Avg
0.69%
3Y Avg
0.48%
5Y Avg
0.29%
Market Cap
$49.03B
Net Profit Margin
15.43%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
Market Cap
$48.72B
Net Profit Margin
4.52%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$47.38B
Net Profit Margin
19.53%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Natera, Inc. (NTRA) | $58.77B | -7.11% | -9.45% | -13.87% | -37.99% |
| Cencora, Inc. (COR)vs › | $60.13B | 0.79% | 0.49% | 0.59% | 0.22% |
| Boston Scientific Corporation (BSX)vs › | $63.32B | 17.47% | 12.73% | 10.54% | 8.34% |
| Cardinal Health, Inc. (CAH)vs › | $53.47B | 0.67% | 0.69% | 0.48% | 0.29% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 15.43% | 47.22% | 37.68% | 33.03% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 4.52% | 8.06% | 8.30% | 8.27% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 19.53% | 19.27% | 18.75% | 17.94% |
| Humana Inc. (HUM)vs › | $46.63B | 0.88% | 0.97% | 1.82% | 2.53% |
| Cigna Corporation (CI)vs › | $71.48B | 2.27% | 1.78% | 2.48% | 3.04% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 4.08% | -0.87% | -5.42% | -7.16% |
Operating Margin
-10.7%
Net Profit Margin
-7.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -8.90% |
| 2026-03-31 | -12.21% |
| 2025-12-31 | 7.10% |
| 2025-09-30 | -14.78% |
| 2025-06-30 | -18.47% |
| 2025-03-31 | -13.34% |
| 2024-12-31 | -11.29% |
| 2024-09-30 | -7.18% |
| 2024-06-30 | -9.06% |
| 2024-03-31 | -18.38% |
| 2023-12-31 | -25.08% |
| 2023-09-30 | -40.64% |
| 2023-06-30 | -42.39% |
| 2023-03-31 | -56.64% |
| 2022-12-31 | -65.63% |
| 2022-09-30 | -57.67% |
| 2022-06-30 | -73.23% |
| 2022-03-31 | -71.39% |
| 2021-12-31 | -81.24% |
| 2021-09-30 | -95.67% |
| 2021-06-30 | -81.69% |
| 2021-03-31 | -41.92% |
| 2020-12-31 | -68.00% |
| 2020-09-30 | -59.43% |
| 2020-06-30 | -68.97% |
| 2020-03-31 | -37.62% |
| 2019-12-31 | -42.27% |
| 2019-09-30 | -29.70% |
| 2019-06-30 | -43.60% |
| 2019-03-31 | -51.02% |
| 2018-12-31 | -47.55% |
| 2018-09-30 | -45.37% |
| 2018-06-30 | -53.63% |
| 2018-03-31 | -52.73% |
| 2017-12-31 | -84.63% |
| 2017-09-30 | -47.87% |
| 2017-06-30 | -51.72% |
| 2017-03-31 | -76.67% |
| 2016-12-31 | -76.89% |
| 2016-09-30 | -48.28% |
| 2016-06-30 | -44.54% |
| 2016-03-31 | -14.03% |
| 2015-12-31 | -43.39% |
| 2015-09-30 | -39.25% |
| 2015-06-30 | -43.65% |
| 2015-03-31 | -21.09% |
| 2014-12-31 | 2.51% |
| 2014-09-30 | 8.05% |
| 2014-06-30 | -1.43% |
| 2014-03-31 | -35.23% |
| 2013-12-31 | -20.51% |
| 2013-09-30 | -34.21% |
| 2013-03-31 | -383.01% |
